Dish of the day
Trellus Health (TRLS.L) which is commercialising a scientifically validated, resilience-based, connected health solution for chronic condition management has joined AIM. · Successful Fundraising for gross proceeds of £28.5 million. Market capitalisation of approximately £64.6 million on Admission.
Belluscura has joined AIM (BELL.L). The designer and manufacturer of FDA cleared, lightweight and portable oxygen concentrators has raised gross proceeds of £17.5 million, at an Issue ....

27 May 2021
Small Cap Feast: 28/05/21
Agronomics Limited (ANIC:LON), 12.8 | Alpha Group International PLC (ALPH:LON), 1,840 | Corcel PLC (CRCL:LON), 0 | DXS International Plc (DXSP:PLU), 5.0 | EQTEC PLC (EQT:LON), 0.3 | Synergia Energy Ltd (SYN:LON), 0 | Petards Group plc (PEG:LON), 10.0 | Real Good Food plc (RGD:LON), 1.4 | Shield Therapeutics Plc (STX:LON), 6.3 | Smoove PLC (SMV:LON), 49.5
-
-
-
Hybridan Research Team
-
2 pages
-

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Feast: 28/05/21
Agronomics Limited (ANIC:LON), 12.8 | Alpha Group International PLC (ALPH:LON), 1,840 | Corcel PLC (CRCL:LON), 0 | DXS International Plc (DXSP:PLU), 5.0 | EQTEC PLC (EQT:LON), 0.3 | Synergia Energy Ltd (SYN:LON), 0 | Petards Group plc (PEG:LON), 10.0 | Real Good Food plc (RGD:LON), 1.4 | Shield Therapeutics Plc (STX:LON), 6.3 | Smoove PLC (SMV:LON), 49.5
- Published:
27 May 2021 -
Author:
Hybridan Research Team -
Pages:
2 -
Dish of the day
Trellus Health (TRLS.L) which is commercialising a scientifically validated, resilience-based, connected health solution for chronic condition management has joined AIM. · Successful Fundraising for gross proceeds of £28.5 million. Market capitalisation of approximately £64.6 million on Admission.
Belluscura has joined AIM (BELL.L). The designer and manufacturer of FDA cleared, lightweight and portable oxygen concentrators has raised gross proceeds of £17.5 million, at an Issue ....